GlaxoSmithKline Pharmaceuticals Limited — Dividend/Bonus, 24-10-2024: Record Date

GlaxoSmithKline Pharmaceuticals Limited will hold a Board of Directors meeting on October 29, 2024, to approve the un-audited financial results for Q2 and the first half of the fiscal year ending September 30, 2024. The Board will also consider declaring an interim dividend, with November 7, 2024, set as the record date for dividend payment, if approved.